NCC-Bio is a South Korean biopharmaceutical company founded in 2020 and headquartered in Goyang, focused on developing targeted anti-cancer strategies and therapeutics.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see NCC-Bio →Already a subscriber? Sign in
Xcout Intel tracks NCC-Bio continuously — this profile deepens as new filings, funding, people and hiring data arrive.